{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-123970","form_type":"8-K","ticker":"LYEL","cik":"0001806952","company_name":"Lyell Immunopharma, Inc.","filed_at":"2025-05-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.803915+00:00","generated_at":"2026-05-20T22:41:52.100070+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Lyell shareholders elect Friedman, approve auditor, say-on-pay, and reverse split authorization up to 1-for-25","bullets":["Class I director Catherine Friedman elected with 156.3M votes for (96.3% of votes cast).","Ratification of Ernst & Young as auditor approved: 212.0M for, 0.3M against.","Advisory say-on-pay passed with 160.7M votes for (99.0% of votes cast).","Reverse stock split authorization approved: 199.9M for (94.2% of votes cast), ratio range 1:10 to 1:25 at Board's discretion."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-123970","json":"https://secwatch.observer/filing/0001193125-25-123970.json","markdown":"https://secwatch.observer/filing/0001193125-25-123970.md","text":"https://secwatch.observer/filing/0001193125-25-123970.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1806952/000119312525123970/0001193125-25-123970-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1806952/000119312525123970/d920680d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T22:41:52.100070+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}